866-997-4948(US-Canada Toll Free)

United States MAb Biosimilars Market Report 2017

Published By :

QYResearch

Published Date : Aug 2017

Category :

Pharmaceutical

No. of Pages : 111 Pages

In this report, the United States MAb Biosimilars market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of MAb Biosimilars in these regions, from 2012 to 2022 (forecast).

United States MAb Biosimilars market competition by top manufacturers/players, with MAb Biosimilars sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Biocon
Celltrion
Dr. Reddy's Laboratories
Hospira
3SBio
Accord Healthcare
AET Biotech
Allergan
Alvartis Pharma
Amega Biotech
Amgen
Apotex
BioXpress Therapeutics
Natco Pharma
Sanifo
Synthon

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Synthetic chemicls
Biopharmaceuticals
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of MAb Biosimilars for each application, including
Chronic and autoimmune diseases
Oncology

Table of Contents

United States MAb Biosimilars Market Report 2017
1 MAb Biosimilars Overview
1.1 Product Overview and Scope of MAb Biosimilars
1.2 Classification of MAb Biosimilars by Product Category
1.2.1 United States MAb Biosimilars Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States MAb Biosimilars Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Synthetic chemicls
1.2.4 Biopharmaceuticals
1.2.5 Others
1.3 United States MAb Biosimilars Market by Application/End Users
1.3.1 United States MAb Biosimilars Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Chronic and autoimmune diseases
1.3.3 Oncology
1.4 United States MAb Biosimilars Market by Region
1.4.1 United States MAb Biosimilars Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West MAb Biosimilars Status and Prospect (2012-2022)
1.4.3 Southwest MAb Biosimilars Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic MAb Biosimilars Status and Prospect (2012-2022)
1.4.5 New England MAb Biosimilars Status and Prospect (2012-2022)
1.4.6 The South MAb Biosimilars Status and Prospect (2012-2022)
1.4.7 The Midwest MAb Biosimilars Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of MAb Biosimilars (2012-2022)
1.5.1 United States MAb Biosimilars Sales and Growth Rate (2012-2022)
1.5.2 United States MAb Biosimilars Revenue and Growth Rate (2012-2022)

2 United States MAb Biosimilars Market Competition by Players/Suppliers
2.1 United States MAb Biosimilars Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States MAb Biosimilars Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States MAb Biosimilars Average Price by Players/Suppliers (2012-2017)
2.4 United States MAb Biosimilars Market Competitive Situation and Trends
2.4.1 United States MAb Biosimilars Market Concentration Rate
2.4.2 United States MAb Biosimilars Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers MAb Biosimilars Manufacturing Base Distribution, Sales Area, Product Type

3 United States MAb Biosimilars Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States MAb Biosimilars Sales and Market Share by Region (2012-2017)
3.2 United States MAb Biosimilars Revenue and Market Share by Region (2012-2017)
3.3 United States MAb Biosimilars Price by Region (2012-2017)

4 United States MAb Biosimilars Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States MAb Biosimilars Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States MAb Biosimilars Revenue and Market Share by Type (2012-2017)
4.3 United States MAb Biosimilars Price by Type (2012-2017)
4.4 United States MAb Biosimilars Sales Growth Rate by Type (2012-2017)

5 United States MAb Biosimilars Sales (Volume) by Application (2012-2017)
5.1 United States MAb Biosimilars Sales and Market Share by Application (2012-2017)
5.2 United States MAb Biosimilars Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States MAb Biosimilars Players/Suppliers Profiles and Sales Data
6.1 Biocon
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 MAb Biosimilars Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Biocon MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Celltrion
6.2.2 MAb Biosimilars Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Celltrion MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Dr. Reddy's Laboratories
6.3.2 MAb Biosimilars Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Dr. Reddy's Laboratories MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Hospira
6.4.2 MAb Biosimilars Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Hospira MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 3SBio
6.5.2 MAb Biosimilars Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 3SBio MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Accord Healthcare
6.6.2 MAb Biosimilars Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Accord Healthcare MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 AET Biotech
6.7.2 MAb Biosimilars Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 AET Biotech MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Allergan
6.8.2 MAb Biosimilars Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Allergan MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Alvartis Pharma
6.9.2 MAb Biosimilars Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Alvartis Pharma MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Amega Biotech
6.10.2 MAb Biosimilars Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Amega Biotech MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Amgen
6.12 Apotex
6.13 BioXpress Therapeutics
6.14 Natco Pharma
6.15 Sanifo
6.16 Synthon

7 MAb Biosimilars Manufacturing Cost Analysis
7.1 MAb Biosimilars Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of MAb Biosimilars

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 MAb Biosimilars Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of MAb Biosimilars Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States MAb Biosimilars Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States MAb Biosimilars Sales Volume, Revenue Forecast (2017-2022)
11.2 United States MAb Biosimilars Sales Volume Forecast by Type (2017-2022)
11.3 United States MAb Biosimilars Sales Volume Forecast by Application (2017-2022)
11.4 United States MAb Biosimilars Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of MAb Biosimilars
Figure United States MAb Biosimilars Market Size (K Units) by Type (2012-2022)
Figure United States MAb Biosimilars Sales Volume Market Share by Type (Product Category) in 2016
Figure Synthetic chemicls Product Picture
Figure Biopharmaceuticals Product Picture
Figure Others Product Picture
Figure United States MAb Biosimilars Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of MAb Biosimilars by Application in 2016
Figure Chronic and autoimmune diseases Examples
Figure Oncology Examples
Figure United States MAb Biosimilars Market Size (Million USD) by Region (2012-2022)
Figure The West MAb Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest MAb Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic MAb Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England MAb Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US MAb Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest MAb Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States MAb Biosimilars Sales (K Units) and Growth Rate (2012-2022)
Figure United States MAb Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States MAb Biosimilars Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States MAb Biosimilars Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States MAb Biosimilars Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States MAb Biosimilars Sales Share by Players/Suppliers
Figure 2017 United States MAb Biosimilars Sales Share by Players/Suppliers
Figure United States MAb Biosimilars Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States MAb Biosimilars Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States MAb Biosimilars Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States MAb Biosimilars Revenue Share by Players/Suppliers
Figure 2017 United States MAb Biosimilars Revenue Share by Players/Suppliers
Table United States Market MAb Biosimilars Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market MAb Biosimilars Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States MAb Biosimilars Market Share of Top 3 Players/Suppliers
Figure United States MAb Biosimilars Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers MAb Biosimilars Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers MAb Biosimilars Product Category
Table United States MAb Biosimilars Sales (K Units) by Region (2012-2017)
Table United States MAb Biosimilars Sales Share by Region (2012-2017)
Figure United States MAb Biosimilars Sales Share by Region (2012-2017)
Figure United States MAb Biosimilars Sales Market Share by Region in 2016
Table United States MAb Biosimilars Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States MAb Biosimilars Revenue Share by Region (2012-2017)
Figure United States MAb Biosimilars Revenue Market Share by Region (2012-2017)
Figure United States MAb Biosimilars Revenue Market Share by Region in 2016
Table United States MAb Biosimilars Price (USD/Unit) by Region (2012-2017)
Table United States MAb Biosimilars Sales (K Units) by Type (2012-2017)
Table United States MAb Biosimilars Sales Share by Type (2012-2017)
Figure United States MAb Biosimilars Sales Share by Type (2012-2017)
Figure United States MAb Biosimilars Sales Market Share by Type in 2016
Table United States MAb Biosimilars Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States MAb Biosimilars Revenue Share by Type (2012-2017)
Figure Revenue Market Share of MAb Biosimilars by Type (2012-2017)
Figure Revenue Market Share of MAb Biosimilars by Type in 2016
Table United States MAb Biosimilars Price (USD/Unit) by Types (2012-2017)
Figure United States MAb Biosimilars Sales Growth Rate by Type (2012-2017)
Table United States MAb Biosimilars Sales (K Units) by Application (2012-2017)
Table United States MAb Biosimilars Sales Market Share by Application (2012-2017)
Figure United States MAb Biosimilars Sales Market Share by Application (2012-2017)
Figure United States MAb Biosimilars Sales Market Share by Application in 2016
Table United States MAb Biosimilars Sales Growth Rate by Application (2012-2017)
Figure United States MAb Biosimilars Sales Growth Rate by Application (2012-2017)
Table Biocon Basic Information List
Table Biocon MAb Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Biocon MAb Biosimilars Sales Growth Rate (2012-2017)
Figure Biocon MAb Biosimilars Sales Market Share in United States (2012-2017)
Figure Biocon MAb Biosimilars Revenue Market Share in United States (2012-2017)
Table Celltrion Basic Information List
Table Celltrion MAb Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Celltrion MAb Biosimilars Sales Growth Rate (2012-2017)
Figure Celltrion MAb Biosimilars Sales Market Share in United States (2012-2017)
Figure Celltrion MAb Biosimilars Revenue Market Share in United States (2012-2017)
Table Dr. Reddy's Laboratories Basic Information List
Table Dr. Reddy's Laboratories MAb Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Dr. Reddy's Laboratories MAb Biosimilars Sales Growth Rate (2012-2017)
Figure Dr. Reddy's Laboratories MAb Biosimilars Sales Market Share in United States (2012-2017)
Figure Dr. Reddy's Laboratories MAb Biosimilars Revenue Market Share in United States (2012-2017)
Table Hospira Basic Information List
Table Hospira MAb Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Hospira MAb Biosimilars Sales Growth Rate (2012-2017)
Figure Hospira MAb Biosimilars Sales Market Share in United States (2012-2017)
Figure Hospira MAb Biosimilars Revenue Market Share in United States (2012-2017)
Table 3SBio Basic Information List
Table 3SBio MAb Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure 3SBio MAb Biosimilars Sales Growth Rate (2012-2017)
Figure 3SBio MAb Biosimilars Sales Market Share in United States (2012-2017)
Figure 3SBio MAb Biosimilars Revenue Market Share in United States (2012-2017)
Table Accord Healthcare Basic Information List
Table Accord Healthcare MAb Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Accord Healthcare MAb Biosimilars Sales Growth Rate (2012-2017)
Figure Accord Healthcare MAb Biosimilars Sales Market Share in United States (2012-2017)
Figure Accord Healthcare MAb Biosimilars Revenue Market Share in United States (2012-2017)
Table AET Biotech Basic Information List
Table AET Biotech MAb Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AET Biotech MAb Biosimilars Sales Growth Rate (2012-2017)
Figure AET Biotech MAb Biosimilars Sales Market Share in United States (2012-2017)
Figure AET Biotech MAb Biosimilars Revenue Market Share in United States (2012-2017)
Table Allergan Basic Information List
Table Allergan MAb Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Allergan MAb Biosimilars Sales Growth Rate (2012-2017)
Figure Allergan MAb Biosimilars Sales Market Share in United States (2012-2017)
Figure Allergan MAb Biosimilars Revenue Market Share in United States (2012-2017)
Table Alvartis Pharma Basic Information List
Table Alvartis Pharma MAb Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Alvartis Pharma MAb Biosimilars Sales Growth Rate (2012-2017)
Figure Alvartis Pharma MAb Biosimilars Sales Market Share in United States (2012-2017)
Figure Alvartis Pharma MAb Biosimilars Revenue Market Share in United States (2012-2017)
Table Amega Biotech Basic Information List
Table Amega Biotech MAb Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amega Biotech MAb Biosimilars Sales Growth Rate (2012-2017)
Figure Amega Biotech MAb Biosimilars Sales Market Share in United States (2012-2017)
Figure Amega Biotech MAb Biosimilars Revenue Market Share in United States (2012-2017)
Table Amgen Basic Information List
Table Apotex Basic Information List
Table BioXpress Therapeutics Basic Information List
Table Natco Pharma Basic Information List
Table Sanifo Basic Information List
Table Synthon Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of MAb Biosimilars
Figure Manufacturing Process Analysis of MAb Biosimilars
Figure MAb Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of MAb Biosimilars Major Players/Suppliers in 2016
Table Major Buyers of MAb Biosimilars
Table Distributors/Traders List
Figure United States MAb Biosimilars Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States MAb Biosimilars Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States MAb Biosimilars Price (USD/Unit) Trend Forecast (2017-2022)
Table United States MAb Biosimilars Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States MAb Biosimilars Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States MAb Biosimilars Sales Volume (K Units) Forecast by Type in 2022
Table United States MAb Biosimilars Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States MAb Biosimilars Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States MAb Biosimilars Sales Volume (K Units) Forecast by Application in 2022
Table United States MAb Biosimilars Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States MAb Biosimilars Sales Volume Share Forecast by Region (2017-2022)
Figure United States MAb Biosimilars Sales Volume Share Forecast by Region (2017-2022)
Figure United States MAb Biosimilars Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *